Gilead’s HIV franchise generated $19.612B in 2024, but faces future funding challenges. Learn why GILD stock is a "Hold" amid ...

Cytokinetics, Incorporated’s CYTK share price has surged by 13.20%, which has investors questioning if this is right time to ...

Edgewise Therapeutics, Inc.’s EWTX share price has dipped by 28.51%, which has investors questioning if this is right time to ...

SOUTH SAN FRANCISCO, CA, USA I April 01, 2025 I TheRas, Inc. d/b/a BridgeBio Oncology Therapeutics (“BBOT” or the “Company”), a clinical-stage ...

Houston sophomore forward Joseph Tugler has been a strong defensive presence during the Cougars’ run to the Final Four. What ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Top minds at the world’s largest atom smasher have released a blueprint for a much bigger successor that could vastly improve ...

All intellectual and work property derived from DiagnaMed’s research activities in amyotrophic lateral sclerosis (ALS) and its Orphan Drug Designation (ODD) for molecular hydrogen in the treatment of ...

UCLA genetic scientists are reawakening hibernating follicles. A UCLA-discovered molecule, PP405, may finally offer real hope ...

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A ...

In the current study, the team exploited this approach to measure the concentration of a single molecule, namely glucose. They used polarised light — a light wave that oscillates only in a ...

Shares of Incyte INCY were down 8.62% on Monday after the announcement of data from two late-stage studies on an oral small-molecule JAK1 inhibitor, povorcitinib, for the treatment of hidradenitis ...